<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01090297</url>
  </required_header>
  <id_info>
    <org_study_id>AGIR-01</org_study_id>
    <nct_id>NCT01090297</nct_id>
  </id_info>
  <brief_title>Continuous Positive Airway Pressure (CPAP) Mode Impact on Clinical Blood Arterial Pressure</brief_title>
  <acronym>AgirSASadom</acronym>
  <official_title>CPAP Treatment : Fixed Versus Auto-adjusting Mode Impact on Clinical Blood Arterial Pressure. Randomised, Controlled and Double Blinded Trial in SAOS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AGIR à Dom</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AGIR à Dom</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Continuous positive airway pressure (CPAP) is the first line therapy for&#xD;
      obstructive sleep apnea syndrome (OSAS). Two positive airway pressure (PAP) modalities can be&#xD;
      used: Fixed pressure, in which the effective pressure is set and kept constant all night, and&#xD;
      auto CPAP devices where the positive pressure changes during the night depend on patient's&#xD;
      requirements.&#xD;
&#xD;
      Hypothesis: Pressure variations associated with autoCPAP functioning can lead to sleep&#xD;
      fragmentation and alterations in sleep structure. This can limit blood pressure dipping&#xD;
      during sleep and then impact clinical blood pressure reduction.&#xD;
&#xD;
      Main objective: To compare in a randomized controlled trial 4 months clinical blood pressure&#xD;
      (BP) evolution depending on CPAP mode: fixed pressure versus autoCPAP. Secondary outcomes:&#xD;
      Evolution of arterial stiffness, biological parameters, quality of life and symptoms.&#xD;
&#xD;
      Methods: Patients will be randomised depending on CPAP mode. Baseline and 4 months evaluation&#xD;
      will include: 24-h ambulatory blood pressure monitoring, clinical BP measurements and&#xD;
      carotid-to-femoral pulse wave velocity (PWV). Patients will also complete quality of life and&#xD;
      symptoms questionnaires.&#xD;
&#xD;
      2 interim analysis will be carried out when 150 and 220 patients respectively will have&#xD;
      completed the study. The Peto's method will be used to correct the p-values.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical blood pressure</measure>
    <time_frame>Before treatment, 4 months after treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulse Wave Velocity</measure>
    <time_frame>Before treatment, 4 months after treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 hours Blood Pressure measure</measure>
    <time_frame>Before treatment, after 4 months of treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">322</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Fixed pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Auto-adjusting pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>S8 Spirit 2</intervention_name>
    <description>3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto.&#xD;
These 3 types of CPAP can be set in both mode of pressure.</description>
    <arm_group_label>Auto-adjusting pressure</arm_group_label>
    <arm_group_label>Fixed pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Somnosmart 2</intervention_name>
    <description>3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto.&#xD;
These 3 types of CPAP can be set in both mode of pressure.</description>
    <arm_group_label>Auto-adjusting pressure</arm_group_label>
    <arm_group_label>Fixed pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Remstar Auto</intervention_name>
    <description>3 types of Continuous Positive Airway Pressure (CPAP) device: S8 Spirit 2, Somnosmart 2, Remstar Auto.&#xD;
These 3 types of CPAP can be set in both mode of pressure.</description>
    <arm_group_label>Auto-adjusting pressure</arm_group_label>
    <arm_group_label>Fixed pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 18 and 80 years&#xD;
&#xD;
          -  patients who gave written informed consent&#xD;
&#xD;
          -  patients who subscribed a social insurance&#xD;
&#xD;
          -  SAOS patients who need CPAP treatment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cardiac failure known and treated&#xD;
&#xD;
          -  central Apnea syndrome&#xD;
&#xD;
          -  patients who stopped CPAP treatment in the previous year&#xD;
&#xD;
          -  pregnant women&#xD;
&#xD;
          -  patients under guardianship&#xD;
&#xD;
          -  imprisoned patients, patients in hospital&#xD;
&#xD;
          -  patients included in an other clinical study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AGIR à Dom</name>
      <address>
        <city>Meylan</city>
        <zip>38240</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <study_first_submitted>March 18, 2010</study_first_submitted>
  <study_first_submitted_qc>March 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2010</study_first_posted>
  <last_update_submitted>February 14, 2013</last_update_submitted>
  <last_update_submitted_qc>February 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 15, 2013</last_update_posted>
  <responsible_party>
    <name_title>Jean Louis PEPIN</name_title>
    <organization>CHU de Grenoble</organization>
  </responsible_party>
  <keyword>Obstructive Sleep Apnea Syndrome</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Continuous Positive Airway Pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

